Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 Study to Determine the Intranasal Allergen Threshold to Food Proteins in Children With Food Allergy

NCT02159833 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT02159833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02159833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 Study to Determine the Intranasal Allergen Threshold to Food Proteins in Children With Food Allergy
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2014
Completion date
January 4, 2019
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

food allergy